Ngenla
Active substance: somatrogon
INJECTION, SOLUTION · SOMATROGON 60 mg/1.2mL
United StatesActive
Marketing holder: Pfizer Laboratories Div Pfizer Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SOMATROGON · 60 mg/1.2mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3e12-7443-b94b-4c895d3204c2,01a1208f-559d-703c-bb4e-2f414acf96fa;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0069-0520
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0069-0520 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0069-0520 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0069-0520 · Verified 2026-10-09 · open in source